

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.13981079 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.60082332 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.51389923 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.51389923 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.21803841 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21237075 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.20354508 |
| 8 | negative thymic T cell selection (GO:0045060) | 4.73311198 |
| 9 | negative T cell selection (GO:0043383) | 4.71843753 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.67383291 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.59849519 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.54198859 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.54198859 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.54198859 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.54198859 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.54198859 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.54198859 |
| 18 | negative regulation of cell killing (GO:0031342) | 4.52467731 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52467731 |
| 20 | T cell migration (GO:0072678) | 4.48007267 |
| 21 | * leukocyte aggregation (GO:0070486) | 4.47290444 |
| 22 | detection of bacterium (GO:0016045) | 4.39242147 |
| 23 | detection of other organism (GO:0098543) | 4.32531119 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.32231007 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.30275113 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.18702192 |
| 27 | response to interleukin-15 (GO:0070672) | 4.18191287 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.16538027 |
| 29 | sequestering of actin monomers (GO:0042989) | 4.01656357 |
| 30 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.00787265 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.98163435 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.96788629 |
| 33 | mast cell activation (GO:0045576) | 3.93437896 |
| 34 | thymic T cell selection (GO:0045061) | 3.90101950 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.88132700 |
| 36 | interferon-gamma production (GO:0032609) | 3.87059507 |
| 37 | positive T cell selection (GO:0043368) | 3.79466322 |
| 38 | cellular response to zinc ion (GO:0071294) | 3.79433713 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.74534098 |
| 40 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.73346691 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 3.72742573 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.71882665 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.68432372 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64691630 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.63642127 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 3.61588262 |
| 47 | respiratory burst (GO:0045730) | 3.60271809 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56460082 |
| 49 | T cell selection (GO:0045058) | 3.54374572 |
| 50 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.53044756 |
| 51 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.51912008 |
| 52 | T cell costimulation (GO:0031295) | 3.50493684 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.48653526 |
| 54 | lymphocyte costimulation (GO:0031294) | 3.47736154 |
| 55 | T cell receptor signaling pathway (GO:0050852) | 3.41276792 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39386455 |
| 57 | ribosomal small subunit assembly (GO:0000028) | 3.38222544 |
| 58 | defense response to protozoan (GO:0042832) | 3.37279639 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.34572982 |
| 60 | detection of external biotic stimulus (GO:0098581) | 3.34352858 |
| 61 | response to type I interferon (GO:0034340) | 3.33523948 |
| 62 | cellular response to type I interferon (GO:0071357) | 3.32588289 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.32588289 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.31924456 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.31397052 |
| 66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.29567492 |
| 67 | cellular extravasation (GO:0045123) | 3.28707568 |
| 68 | response to host immune response (GO:0052572) | 3.27477833 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27477833 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.27206534 |
| 71 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.25192793 |
| 72 | response to protozoan (GO:0001562) | 3.23579383 |
| 73 | DNA deamination (GO:0045006) | 3.22322829 |
| 74 | B cell mediated immunity (GO:0019724) | 3.20924165 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 3.19777804 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 3.18532299 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18147515 |
| 78 | positive regulation of isotype switching (GO:0045830) | 3.16955906 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16771626 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.16368411 |
| 81 | T cell homeostasis (GO:0043029) | 3.16076500 |
| 82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14975981 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12654849 |
| 84 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.10841106 |
| 85 | actin nucleation (GO:0045010) | 3.07695987 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07127654 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06097116 |
| 88 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05072444 |
| 89 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05063725 |
| 90 | tolerance induction (GO:0002507) | 3.03842286 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 3.03302054 |
| 92 | response to host (GO:0075136) | 3.00875181 |
| 93 | response to host defenses (GO:0052200) | 3.00875181 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00875181 |
| 95 | natural killer cell activation (GO:0030101) | 2.99824179 |
| 96 | mast cell activation involved in immune response (GO:0002279) | 2.97730182 |
| 97 | mast cell degranulation (GO:0043303) | 2.97730182 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 2.97431420 |
| 99 | activated T cell proliferation (GO:0050798) | 2.97140209 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.95862922 |
| 101 | regulation of B cell mediated immunity (GO:0002712) | 2.95790424 |
| 102 | * leukocyte cell-cell adhesion (GO:0007159) | 2.95584558 |
| 103 | regulation of response to interferon-gamma (GO:0060330) | 2.94773298 |
| 104 | negative regulation of innate immune response (GO:0045824) | 2.92891006 |
| 105 | detection of biotic stimulus (GO:0009595) | 2.92176430 |
| 106 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.91578057 |
| 107 | positive regulation of B cell mediated immunity (GO:0002714) | 2.91578057 |
| 108 | neutrophil activation (GO:0042119) | 2.91133949 |
| 109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90943977 |
| 110 | positive regulation of tolerance induction (GO:0002645) | 2.90846469 |
| 111 | regulation of T cell tolerance induction (GO:0002664) | 2.88504851 |
| 112 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.87966298 |
| 113 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.87399030 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87257065 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.87038620 |
| 116 | cellular response to interferon-beta (GO:0035458) | 2.86277675 |
| 117 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.85849112 |
| 118 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.85849112 |
| 119 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.85824954 |
| 120 | germinal center formation (GO:0002467) | 2.84352046 |
| 121 | response to peptidoglycan (GO:0032494) | 2.82171770 |
| 122 | regulation of isotype switching (GO:0045191) | 2.80071763 |
| 123 | lymphocyte homeostasis (GO:0002260) | 2.79977435 |
| 124 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.78981377 |
| 125 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.77709668 |
| 126 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.77181563 |
| 127 | positive regulation of DNA recombination (GO:0045911) | 2.76658626 |
| 128 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.74111838 |
| 129 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.74111838 |
| 130 | leukocyte degranulation (GO:0043299) | 2.73403340 |
| 131 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.71692170 |
| 132 | cellular defense response (GO:0006968) | 2.71651736 |
| 133 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71492661 |
| 134 | positive regulation of interleukin-2 production (GO:0032743) | 2.71154542 |
| 135 | granulocyte activation (GO:0036230) | 2.65088458 |
| 136 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.64584444 |
| 137 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.64260324 |
| 138 | positive regulation of immunoglobulin production (GO:0002639) | 2.61507588 |
| 139 | regulation of necroptotic process (GO:0060544) | 2.60990803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.12838746 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75557247 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.22308608 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.90480228 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78549770 |
| 6 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77441080 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45145466 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.23685555 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88770469 |
| 10 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.85680630 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.85220661 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.79797608 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73788426 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.72063183 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.67196517 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56508747 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.54756743 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49834820 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43052522 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.42904311 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38747465 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.37475095 |
| 23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30334558 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.29013771 |
| 25 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28884035 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25309892 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25034626 |
| 28 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18674162 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 2.18011300 |
| 30 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16597288 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16113706 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.13565570 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05541891 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00077311 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98352054 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91307598 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85343313 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84535339 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81564867 |
| 40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80081646 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.78917616 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.77956121 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.77758815 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71046185 |
| 45 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69474433 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65017200 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60884956 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55672936 |
| 49 | * MAF_26560356_Chip-Seq_TH2_Human | 1.53697945 |
| 50 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53503508 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53415447 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53270563 |
| 53 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.48882689 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48040623 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.45992303 |
| 56 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45153043 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43539514 |
| 58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.42725698 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42270499 |
| 60 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40116633 |
| 61 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.39854614 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.38110568 |
| 63 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37316902 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36461829 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29401948 |
| 66 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27103672 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26997237 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26692480 |
| 69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.24258755 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22554298 |
| 71 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20454989 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19218159 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18849279 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17275435 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15915284 |
| 76 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15674514 |
| 77 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15535723 |
| 78 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12974123 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11916274 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11582294 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08290860 |
| 82 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.07911121 |
| 83 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.06410305 |
| 84 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.05710677 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05383926 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05083217 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03444301 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02720995 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02703825 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01273089 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01075480 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00776754 |
| 93 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00737139 |
| 94 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00698302 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00422313 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98764416 |
| 97 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97973368 |
| 98 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97002470 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96948615 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96644154 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96326695 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96144991 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95959336 |
| 104 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95678819 |
| 105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92684568 |
| 106 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92527383 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92360664 |
| 108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91742959 |
| 109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91287257 |
| 110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91067257 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.90993490 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90657330 |
| 113 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.89529779 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89241024 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88448237 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88365119 |
| 117 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.87570167 |
| 118 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.86203379 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85918651 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84969455 |
| 121 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84632325 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84490079 |
| 123 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84386160 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82388218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40712032 |
| 2 | MP0005671_abnormal_response_to | 4.21588946 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.74160981 |
| 4 | MP0009785_altered_susceptibility_to | 3.69412983 |
| 5 | MP0000685_abnormal_immune_system | 3.54472249 |
| 6 | MP0001800_abnormal_humoral_immune | 3.22496446 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.04115360 |
| 8 | MP0001790_abnormal_immune_system | 3.02242954 |
| 9 | MP0005387_immune_system_phenotype | 3.02242954 |
| 10 | MP0003436_decreased_susceptibility_to | 3.01742974 |
| 11 | * MP0005025_abnormal_response_to | 2.93658031 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.89066803 |
| 13 | * MP0001819_abnormal_immune_cell | 2.85483038 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.84779561 |
| 15 | * MP0002723_abnormal_immune_serum | 2.79986431 |
| 16 | * MP0002398_abnormal_bone_marrow | 2.67585247 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.59514255 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.59077470 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.58760819 |
| 20 | * MP0002419_abnormal_innate_immunity | 2.55652194 |
| 21 | MP0002405_respiratory_system_inflammati | 2.42614592 |
| 22 | * MP0000716_abnormal_immune_system | 2.41111287 |
| 23 | MP0006082_CNS_inflammation | 2.40211508 |
| 24 | MP0003724_increased_susceptibility_to | 2.38805065 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.22893521 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.20831980 |
| 27 | MP0002722_abnormal_immune_system | 2.20055308 |
| 28 | MP0003303_peritoneal_inflammation | 2.19970320 |
| 29 | MP0002006_tumorigenesis | 2.18204814 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.12104731 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.08344254 |
| 32 | * MP0002429_abnormal_blood_cell | 2.03462000 |
| 33 | MP0001853_heart_inflammation | 1.97941509 |
| 34 | MP0001873_stomach_inflammation | 1.94451026 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.94217251 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.84438262 |
| 37 | MP0003866_abnormal_defecation | 1.78772341 |
| 38 | MP0004947_skin_inflammation | 1.71921965 |
| 39 | MP0002933_joint_inflammation | 1.63607797 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.61461309 |
| 41 | MP0000858_altered_metastatic_potential | 1.58248350 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.55981775 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.55981775 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.52796212 |
| 45 | MP0000490_abnormal_crypts_of | 1.47605761 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.42954997 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.38550429 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.36050166 |
| 49 | * MP0008469_abnormal_protein_level | 1.33169904 |
| 50 | MP0005310_abnormal_salivary_gland | 1.30643439 |
| 51 | MP0008057_abnormal_DNA_replication | 1.28548591 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.27465657 |
| 53 | MP0010094_abnormal_chromosome_stability | 1.24261636 |
| 54 | MP0003448_altered_tumor_morphology | 1.23880342 |
| 55 | MP0004510_myositis | 1.22596720 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.22556505 |
| 57 | MP0002132_abnormal_respiratory_system | 1.19475923 |
| 58 | MP0005451_abnormal_body_composition | 1.17040696 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.15176987 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.13370534 |
| 61 | MP0009278_abnormal_bone_marrow | 1.12794398 |
| 62 | MP0008260_abnormal_autophagy | 1.11168019 |
| 63 | MP0009764_decreased_sensitivity_to | 1.10069421 |
| 64 | MP0003077_abnormal_cell_cycle | 1.05309453 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.00655022 |
| 66 | MP0001851_eye_inflammation | 0.99665254 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 0.98495959 |
| 68 | MP0000343_altered_response_to | 0.98001690 |
| 69 | MP0000015_abnormal_ear_pigmentation | 0.96386361 |
| 70 | MP0002095_abnormal_skin_pigmentation | 0.93543331 |
| 71 | MP0003172_abnormal_lysosome_physiology | 0.91556211 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.90974591 |
| 73 | MP0008058_abnormal_DNA_repair | 0.89880278 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.88835093 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.87337647 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.85810746 |
| 77 | MP0003111_abnormal_nucleus_morphology | 0.84507947 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 0.82690798 |
| 79 | MP0004883_abnormal_blood_vessel | 0.81549198 |
| 80 | * MP0009763_increased_sensitivity_to | 0.76222316 |
| 81 | MP0010307_abnormal_tumor_latency | 0.75081036 |
| 82 | MP0004381_abnormal_hair_follicle | 0.73976396 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.70673258 |
| 84 | MP0000604_amyloidosis | 0.69521670 |
| 85 | MP0005166_decreased_susceptibility_to | 0.69132028 |
| 86 | MP0001663_abnormal_digestive_system | 0.67342200 |
| 87 | MP0000313_abnormal_cell_death | 0.66453261 |
| 88 | MP0005164_abnormal_response_to | 0.64959524 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.62897506 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.60517728 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.60502565 |
| 92 | MP0009840_abnormal_foam_cell | 0.59527927 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.58475462 |
| 94 | MP0006054_spinal_hemorrhage | 0.57011165 |
| 95 | MP0000477_abnormal_intestine_morphology | 0.56965828 |
| 96 | MP0003828_pulmonary_edema | 0.56776722 |
| 97 | MP0008874_decreased_physiological_sensi | 0.56370513 |
| 98 | MP0008004_abnormal_stomach_pH | 0.54148340 |
| 99 | MP0005390_skeleton_phenotype | 0.52365984 |
| 100 | MP0003795_abnormal_bone_structure | 0.52140717 |
| 101 | * MP0000249_abnormal_blood_vessel | 0.51737716 |
| 102 | MP0002009_preneoplasia | 0.50460746 |
| 103 | MP0003690_abnormal_glial_cell | 0.49997142 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.49458729 |
| 105 | MP0001191_abnormal_skin_condition | 0.49283596 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.48059313 |
| 107 | MP0008873_increased_physiological_sensi | 0.47560964 |
| 108 | MP0003075_altered_response_to | 0.46983901 |
| 109 | MP0000609_abnormal_liver_physiology | 0.46303226 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.45710474 |
| 111 | MP0003186_abnormal_redox_activity | 0.43404500 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.43337349 |
| 113 | MP0003045_fibrosis | 0.42190481 |
| 114 | MP0000371_diluted_coat_color | 0.41004985 |
| 115 | MP0003786_premature_aging | 0.38130590 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37076054 |
| 117 | * MP0009642_abnormal_blood_homeostasis | 0.36612383 |
| 118 | MP0000598_abnormal_liver_morphology | 0.36358033 |
| 119 | MP0002083_premature_death | 0.36207022 |
| 120 | MP0005083_abnormal_biliary_tract | 0.35855265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.55275370 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.40351516 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.12865925 |
| 4 | IgM deficiency (HP:0002850) | 4.74020774 |
| 5 | Recurrent bronchitis (HP:0002837) | 4.66521965 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.59327642 |
| 7 | T lymphocytopenia (HP:0005403) | 4.54919880 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.48331978 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.46790918 |
| 10 | Stomatitis (HP:0010280) | 4.43244120 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.27633782 |
| 12 | Myositis (HP:0100614) | 4.21891475 |
| 13 | Abnormality of T cells (HP:0002843) | 4.17767470 |
| 14 | Chronic otitis media (HP:0000389) | 4.17669751 |
| 15 | IgG deficiency (HP:0004315) | 4.08490730 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.06302212 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.06302212 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.99711093 |
| 19 | Recurrent viral infections (HP:0004429) | 3.97465879 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.90299645 |
| 21 | Meningitis (HP:0001287) | 3.84875965 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.82218380 |
| 23 | Thyroiditis (HP:0100646) | 3.79966986 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.79963414 |
| 25 | Obstructive lung disease (HP:0006536) | 3.79963414 |
| 26 | Recurrent skin infections (HP:0001581) | 3.70221895 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.64911769 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.63789445 |
| 29 | Lymphopenia (HP:0001888) | 3.52486970 |
| 30 | Thrombocytosis (HP:0001894) | 3.48838245 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46739164 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.44074137 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37336140 |
| 34 | Increased IgM level (HP:0003496) | 3.34995916 |
| 35 | B lymphocytopenia (HP:0010976) | 3.30344837 |
| 36 | Abnormality of B cell number (HP:0010975) | 3.30344837 |
| 37 | Cellulitis (HP:0100658) | 3.27955447 |
| 38 | Nasal polyposis (HP:0100582) | 3.18996662 |
| 39 | Vasculitis (HP:0002633) | 3.18549689 |
| 40 | Recurrent sinusitis (HP:0011108) | 3.16181200 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.14483296 |
| 42 | Abnormality of eosinophils (HP:0001879) | 3.11204959 |
| 43 | Leukocytosis (HP:0001974) | 3.02388898 |
| 44 | Chronic diarrhea (HP:0002028) | 2.99541615 |
| 45 | Gingivitis (HP:0000230) | 2.98104714 |
| 46 | Petechiae (HP:0000967) | 2.92869227 |
| 47 | Hypoplasia of the thymus (HP:0000778) | 2.89734775 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.85363829 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 2.81729720 |
| 50 | Pustule (HP:0200039) | 2.81463299 |
| 51 | IgA deficiency (HP:0002720) | 2.81306338 |
| 52 | Orchitis (HP:0100796) | 2.80834938 |
| 53 | Eosinophilia (HP:0001880) | 2.80694113 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.80645521 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.79484381 |
| 56 | Optic neuritis (HP:0100653) | 2.79484381 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.75177629 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.74577773 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.72454339 |
| 60 | Hypochromic anemia (HP:0001931) | 2.71359218 |
| 61 | Granulocytopenia (HP:0001913) | 2.68492698 |
| 62 | Encephalitis (HP:0002383) | 2.62891379 |
| 63 | Lymphoma (HP:0002665) | 2.62618775 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.60337641 |
| 65 | Bronchitis (HP:0012387) | 2.60276528 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.58544429 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.56148391 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.52661951 |
| 69 | Hemoptysis (HP:0002105) | 2.51288560 |
| 70 | Gingival bleeding (HP:0000225) | 2.50167605 |
| 71 | Recurrent pneumonia (HP:0006532) | 2.43460233 |
| 72 | Pulmonary embolism (HP:0002204) | 2.43317859 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.41958134 |
| 74 | Sepsis (HP:0100806) | 2.38686711 |
| 75 | Aplastic anemia (HP:0001915) | 2.37734150 |
| 76 | Episodic fever (HP:0001954) | 2.36509086 |
| 77 | Chronic sinusitis (HP:0011109) | 2.34606392 |
| 78 | Purpura (HP:0000979) | 2.34453612 |
| 79 | Anorexia (HP:0002039) | 2.33570681 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.32409418 |
| 81 | Colitis (HP:0002583) | 2.31867661 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.31450214 |
| 83 | Epistaxis (HP:0000421) | 2.30390432 |
| 84 | Urticaria (HP:0001025) | 2.29025460 |
| 85 | Abnormality of the fingertips (HP:0001211) | 2.27298714 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26662628 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 2.25015911 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.24012158 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.23260647 |
| 90 | Gangrene (HP:0100758) | 2.22963003 |
| 91 | Reticulocytopenia (HP:0001896) | 2.21540097 |
| 92 | Osteomyelitis (HP:0002754) | 2.21159141 |
| 93 | Papilloma (HP:0012740) | 2.20707446 |
| 94 | Verrucae (HP:0200043) | 2.20707446 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 2.15368674 |
| 96 | Skin ulcer (HP:0200042) | 2.14670168 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 2.13200608 |
| 98 | Increased IgE level (HP:0003212) | 2.12957429 |
| 99 | Acute hepatic failure (HP:0006554) | 2.12211498 |
| 100 | Neutropenia (HP:0001875) | 2.11941820 |
| 101 | Skin rash (HP:0000988) | 2.11640737 |
| 102 | Poikiloderma (HP:0001029) | 2.10954811 |
| 103 | Periodontitis (HP:0000704) | 2.10626944 |
| 104 | Chest pain (HP:0100749) | 2.09469222 |
| 105 | Glomerulopathy (HP:0100820) | 2.09138950 |
| 106 | Increased serum ferritin (HP:0003281) | 2.08800520 |
| 107 | Hypertensive crisis (HP:0100735) | 2.08612506 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.08510529 |
| 109 | Restrictive lung disease (HP:0002091) | 2.01733164 |
| 110 | Joint swelling (HP:0001386) | 2.01295446 |
| 111 | Microcytic anemia (HP:0001935) | 2.00620788 |
| 112 | Premature loss of primary teeth (HP:0006323) | 1.97140064 |
| 113 | Arthralgia (HP:0002829) | 1.96194797 |
| 114 | Recurrent otitis media (HP:0000403) | 1.95203190 |
| 115 | Increased cerebral lipofuscin (HP:0011813) | 1.94973835 |
| 116 | Arterial thrombosis (HP:0004420) | 1.94900929 |
| 117 | Basal ganglia calcification (HP:0002135) | 1.94399820 |
| 118 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.91811606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.17314645 |
| 2 | TXK | 4.11655715 |
| 3 | BLK | 2.85807960 |
| 4 | IRAK4 | 2.77895634 |
| 5 | ZAP70 | 2.73444470 |
| 6 | TESK2 | 2.48818361 |
| 7 | BTK | 2.47558264 |
| 8 | IKBKE | 2.46893822 |
| 9 | TYK2 | 2.43030997 |
| 10 | JAK3 | 2.40039275 |
| 11 | KIT | 2.38285445 |
| 12 | PRPF4B | 2.36733849 |
| 13 | TEC | 2.35863900 |
| 14 | KDR | 2.21091463 |
| 15 | TBK1 | 2.13911716 |
| 16 | ITK | 2.08695047 |
| 17 | STK10 | 1.99491440 |
| 18 | SYK | 1.98365831 |
| 19 | MAP3K14 | 1.91623136 |
| 20 | MAP3K12 | 1.89099051 |
| 21 | GRK6 | 1.82595273 |
| 22 | NME2 | 1.75178728 |
| 23 | LCK | 1.69518865 |
| 24 | CLK1 | 1.65772876 |
| 25 | CSF1R | 1.62994995 |
| 26 | CSK | 1.62107123 |
| 27 | JAK1 | 1.50727360 |
| 28 | FES | 1.45937347 |
| 29 | HCK | 1.44574765 |
| 30 | LYN | 1.39314665 |
| 31 | FGFR4 | 1.37114929 |
| 32 | ERN1 | 1.25621009 |
| 33 | RIPK4 | 1.24573223 |
| 34 | IKBKB | 1.20061749 |
| 35 | TAOK1 | 1.19934221 |
| 36 | NLK | 1.18331873 |
| 37 | MAP3K3 | 1.17517011 |
| 38 | EIF2AK1 | 1.16175528 |
| 39 | BUB1 | 1.15615567 |
| 40 | LRRK2 | 1.14365661 |
| 41 | FGR | 1.10514894 |
| 42 | FLT3 | 1.09516349 |
| 43 | EIF2AK3 | 1.09277699 |
| 44 | SMG1 | 1.06169583 |
| 45 | TAOK2 | 1.06168436 |
| 46 | BMPR2 | 1.03329871 |
| 47 | EEF2K | 1.03180041 |
| 48 | PIM2 | 1.02670511 |
| 49 | PIM1 | 1.00570293 |
| 50 | FGFR3 | 0.99289945 |
| 51 | MAP3K10 | 0.98843116 |
| 52 | RPS6KA4 | 0.98167589 |
| 53 | MAP3K1 | 0.96970197 |
| 54 | ACVR1B | 0.95826046 |
| 55 | IRAK3 | 0.95697397 |
| 56 | TESK1 | 0.92440323 |
| 57 | STK16 | 0.87955932 |
| 58 | MAP2K3 | 0.86887834 |
| 59 | MST4 | 0.84590587 |
| 60 | TNK2 | 0.79848537 |
| 61 | TAOK3 | 0.79250008 |
| 62 | PRKCQ | 0.77455855 |
| 63 | STK4 | 0.76969406 |
| 64 | CDC7 | 0.74269606 |
| 65 | CDK19 | 0.72700336 |
| 66 | TGFBR2 | 0.72413919 |
| 67 | BCKDK | 0.71395740 |
| 68 | TLK1 | 0.70457846 |
| 69 | SIK3 | 0.67715081 |
| 70 | MAPK12 | 0.66377984 |
| 71 | NEK2 | 0.62396274 |
| 72 | CDK4 | 0.59348552 |
| 73 | TGFBR1 | 0.59206708 |
| 74 | JAK2 | 0.58975889 |
| 75 | PRKD2 | 0.56736659 |
| 76 | GRK7 | 0.56318853 |
| 77 | MARK3 | 0.56011236 |
| 78 | SIK2 | 0.55631355 |
| 79 | NEK9 | 0.53881197 |
| 80 | MAP3K13 | 0.53540764 |
| 81 | TRPM7 | 0.53195909 |
| 82 | CHUK | 0.52033539 |
| 83 | ATR | 0.51715822 |
| 84 | MAP3K11 | 0.50996006 |
| 85 | KSR2 | 0.50752194 |
| 86 | PIK3CG | 0.47872937 |
| 87 | PTK6 | 0.46549246 |
| 88 | PKN2 | 0.46493217 |
| 89 | PASK | 0.45894200 |
| 90 | MAPK11 | 0.45574321 |
| 91 | SCYL2 | 0.45557752 |
| 92 | PDPK1 | 0.45531545 |
| 93 | YES1 | 0.45491892 |
| 94 | EPHB1 | 0.45039528 |
| 95 | MAPK7 | 0.45014394 |
| 96 | PRKCH | 0.44834933 |
| 97 | VRK1 | 0.44599098 |
| 98 | WEE1 | 0.44510347 |
| 99 | PRKCD | 0.43479000 |
| 100 | IRAK1 | 0.43365960 |
| 101 | MAPK4 | 0.43350120 |
| 102 | CAMKK1 | 0.42946311 |
| 103 | MAP2K6 | 0.41653440 |
| 104 | RPS6KA6 | 0.41183320 |
| 105 | MAP3K5 | 0.41150457 |
| 106 | MARK2 | 0.41004032 |
| 107 | VRK2 | 0.40300436 |
| 108 | CDC42BPA | 0.39610088 |
| 109 | MAP3K7 | 0.39394490 |
| 110 | MAP2K2 | 0.38468502 |
| 111 | CAMKK2 | 0.37887635 |
| 112 | TRIB3 | 0.37256522 |
| 113 | RAF1 | 0.37098812 |
| 114 | MAP3K8 | 0.36291196 |
| 115 | FYN | 0.35107458 |
| 116 | EIF2AK2 | 0.34842887 |
| 117 | CCNB1 | 0.33720528 |
| 118 | MAPKAPK2 | 0.33496915 |
| 119 | MATK | 0.32966798 |
| 120 | MOS | 0.32804372 |
| 121 | ABL1 | 0.32785735 |
| 122 | RPS6KL1 | 0.31027217 |
| 123 | RPS6KC1 | 0.31027217 |
| 124 | CDK7 | 0.29863118 |
| 125 | ADRBK2 | 0.29545109 |
| 126 | DAPK1 | 0.29491929 |
| 127 | RPS6KB2 | 0.28088739 |
| 128 | AURKB | 0.25468119 |
| 129 | HIPK2 | 0.24566253 |
| 130 | MYLK | 0.24315893 |
| 131 | PRKG2 | 0.23397988 |
| 132 | PDK1 | 0.22937197 |
| 133 | ILK | 0.22039665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.99182320 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.71027910 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.64661648 |
| 4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.60338994 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.58771161 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.46276392 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45545329 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.42383762 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42251359 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.39803310 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37890700 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.20878388 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.20339959 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15411342 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 2.00033348 |
| 16 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96809586 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.86430217 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.86247863 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86131252 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.77993408 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77212013 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71872003 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46406578 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43992237 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41573143 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.41182219 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.38680874 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36366410 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.35137825 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.31610775 |
| 31 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31312222 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29493824 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.27120315 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.25924725 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23665143 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21994226 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20559798 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.18399451 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.18135111 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16969927 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16603575 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.16155342 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.14291565 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.12277372 |
| 45 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11695757 |
| 46 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10017832 |
| 47 | Spliceosome_Homo sapiens_hsa03040 | 1.09674173 |
| 48 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.08693271 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02179282 |
| 50 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99679798 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99454184 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.97508798 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95204656 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89438157 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87885250 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87480255 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85778846 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85704643 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84576224 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.84315522 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81833048 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81072511 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79990216 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78437672 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77198225 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.74187923 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72440827 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71837424 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.69143562 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.62700205 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60974524 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.55165732 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.54888445 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53494236 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52173900 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51890796 |
| 77 | Protein export_Homo sapiens_hsa03060 | 0.51749769 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51495336 |
| 79 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.47481550 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46435075 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44365724 |
| 82 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43978421 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43839081 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42173890 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41280434 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40607855 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40188300 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38025812 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37667178 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.37328060 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.35906845 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35607463 |
| 93 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34474545 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34297404 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33418957 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33040688 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31701382 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30275125 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29753112 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29653453 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28398689 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28286987 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28141710 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28025341 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27423935 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26973961 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26620855 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.26062990 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24629863 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24332519 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23673973 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.23265579 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.22709656 |
| 114 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21137631 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.20042387 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19690453 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17746186 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17092275 |
| 119 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16911993 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14949914 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.14016524 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.12590648 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.12269351 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11755817 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11021917 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10986307 |
| 127 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.08481934 |
| 128 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07157070 |

